Most people receiving electroconvulsive therapy (ECT) begin noticing improvement within the first two to three weeks of treatment, though a full course typically runs three to four weeks. The standard schedule in the U.S. is two to three sessions per week, totaling 6 to 12 treatments. Some treatment centers routinely plan for 10 to 12 sessions at three times per week. That means from the first session to the last, you’re looking at roughly three to six weeks before completing the acute phase of treatment.
When Improvement Typically Starts
ECT works faster than antidepressants, which often take four to six weeks to show results. Some patients report a shift in mood or energy after just a few sessions, while others don’t notice meaningful change until they’re well into the second or third week. The speed of response varies by diagnosis. People with certain features of depression, such as psychotic symptoms or catatonia, tend to respond more quickly and robustly than those with other presentations.
Unlike medication, where you take a pill daily and wait, ECT delivers its effects in a concentrated burst over a short treatment window. Each session builds on the last, so skipping sessions or spacing them too far apart can slow progress. This is why the three-times-per-week schedule is standard at many centers: it keeps momentum going.
What Happens in Your Brain During Treatment
ECT triggers a cascade of biological changes that accumulate over the treatment course. One of the most significant is the growth of new brain cells in the hippocampus, a region critical for mood regulation and memory. Animal studies show this neurogenesis increases in a dose-dependent way, meaning more sessions produce more new cell growth.
At the same time, ECT boosts levels of a key growth factor that supports the survival and flexibility of neurons. It also rebalances several chemical messenger systems in the brain, including serotonin, norepinephrine, and dopamine, all of which are disrupted in severe depression. Glutamate, the brain’s primary excitatory chemical, normalizes in mood-regulating regions, and this normalization correlates directly with how well someone responds to treatment.
There’s also an immune component. Early sessions trigger a short-term inflammatory response, but as treatment continues, the brain adapts and that inflammation actually decreases. This shift from initial activation to longer-term calming mirrors the clinical pattern many patients experience: the first few sessions can feel rough, but things gradually turn a corner.
What Each Session Feels Like
A single ECT session takes about 30 to 60 minutes from check-in to recovery, though the procedure itself lasts only a few minutes. You’re placed under brief general anesthesia, so you’re asleep for the treatment and don’t feel the electrical stimulation. After waking, some confusion or disorientation is common and typically clears within one to two hours. About 5 to 12 percent of patients experience more noticeable agitation during this recovery window.
Cognitive side effects, like difficulty concentrating or feeling foggy, can linger for about 90 minutes after each session. Over the course of treatment, some people notice gaps in memory, particularly for events close to the treatment dates. These deficits generally resolve within days to weeks after the final session, though the timeline varies from person to person.
What Affects How Quickly You Respond
Several factors influence whether you’ll be on the shorter or longer end of the treatment course. The type and severity of your condition matter most. ECT is often recommended precisely because it works more rapidly than medications or therapy, especially in severe or life-threatening situations where delays in recovery could be dangerous.
Electrode placement also plays a role. Your treatment team will choose between placing electrodes on one side of the head (unilateral) or both sides (bilateral), and this decision affects both the speed of response and the cognitive side effect profile. Concurrent medications, overall physical health, and how long you’ve been ill before starting ECT can all shift the timeline as well. People in rural areas, for example, often start ECT later in their illness due to delays in hospital admission, which can complicate the picture.
After the Acute Course Ends
Finishing the initial round of ECT doesn’t mean treatment is over. Relapse rates without any follow-up treatment are high: in one analysis, 78 percent of patients given a placebo after ECT relapsed within six months. That number drops substantially with ongoing care. Patients who took maintenance antidepressants after ECT had a six-month relapse rate of about 38 percent. At one year, roughly half of those on maintenance medication had relapsed.
Continuation ECT, where sessions are gradually spaced out to a reduced schedule, showed similar six-month relapse rates to medication, around 37 percent. Many treatment plans combine both approaches. The tapering schedule varies, but the principle is the same: the biological changes ECT produces need ongoing support to stick. Without it, the brain’s chemistry and circuitry can drift back toward their pre-treatment state.
This means the full timeline for ECT isn’t just the three to six weeks of acute treatment. It includes a maintenance phase that can stretch months or longer, with the goal of preserving the gains made during the initial course.